Alcon Saham

Alcon Rule of 40

Rule of 40 dari Alcon (ALC.SW) pada 15 Agu 2026 adalah 23,01 %. Tahun sebelumnya, Rule of 40 adalah 19,08 % — perubahan sebesar 20,61% (lebih tinggi).

Rule of 40

23,01 %

YoY

20,61%

Terakhir Diperbarui:

Rule of 40 dari Alcon adalah 2026 23,01 % . Rule of 40 dari Alcon adalah 2025 19,08 % . Menurun 20,61% lebih tinggi dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

Alcon Analisis saham

Apa yang dilakukan Alcon? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Alcon

Rule of 40 Alcon adalah 23,01 % pada tahun 2026.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Rule of 40 Alcon sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Rule of 40 menyatakan bahwa tingkat pertumbuhan pendapatan perusahaan ditambah margin laba harus melebihi 40%. Ini banyak digunakan untuk mengevaluasi perusahaan SaaS dan pertumbuhan tinggi.

Access this data via the Eulerpool API

Kualitas — Alcon

Semua Metrik Kunci — Alcon